Rubius Therapeutics, Inc. (RUBY:NASDAQ) jumped higher at $31.78, representing a gain of 26.8%. The stock got featured on our News Catalysts scanner on Thu 18 Mar 21 at 08:39 AM in the 'BIOTECH' category. From Wed 10 Mar 21, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Mon 15 Mar 21 at $38.71 with a volume of 38M+.
About Rubius Therapeutics, Inc. (RUBY:NASDAQ)
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.
Top 10 Gainers:
- GCAC (GCAC:NASDAQ), 100%
- ProQR Therapeutics N.V. (PRQR:NASDAQ), 62.32%
- Koss Corporation (KOSS:NASDAQ), 57.13%
- GameStop Corp. (GME:NYSE), 52.69%
- Immutep Limited (IMMP:NASDAQ), 39.92%
- Houston Wire & Cable Company (HWCC:NASDAQ), 37.63%
- Cellect Biotechnology Ltd. (APOP:NASDAQ), 36.68%
- KBS Fashion Group Limited (KBSF:NASDAQ), 31.3%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 26.77%
- FreightCar America, Inc. (RAIL:NASDAQ), 23.39%